A 52-year-old widow recounts her ordeal after Lagos land grabbers demolished her N30m home, built with her late husband's ...

The FDA approved an extension of dosing intervals for Eylea HD in patients with diabetic macular edema and wet age-related macular degeneration, Regeneron Pharmaceuticals, Inc. announced.The approval, ...

Enbumyst, First and Only FDA-Approved Nasal Spray Loop Diuretic Now Integrated into Esperion’s Cardiovascular Franchise, Anticipated to Drive ...

Regeneron Pharmaceuticals has won Food and Drug Administration approval of extended dosing intervals of up to every 20 weeks for its Eylea HD eye drug.

Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements ...

A REJOINDER TO THE UNWARRANTED ATTACK ON DR COLLINS EDEMA: WHY WARRI DESERVES CAPACITY OVER CLOUT In the evolving landscape of Delta State politics, the word “capacity” is often tossed around by those ...

NEW ORLEANS -- For people with heart failure with preserved ejection fraction (HFpEF), monitoring for early fluid ...

Kodiak Sciences KOD reported fourth-quarter 2025 loss of $1.04 per share, wider than the Zacks Consensus Estimate of a loss ...

Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the re--launch of Hydrochlorothiazide Tablets, USP in 12.5 mg, ...

A multicenter, single-arm, phase 2 trial investigated the activity and safety of varnimcabtagene autoleucel in adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

The Itsekiri Youths for Good Governance (IYGG) have expressed appreciation to Collins Edema for his response to calls urging ...

Treatment management guided by the use of a noninvasive device to monitor fluid accumulation in the lungs substantially reduced hospitalizations and deaths among patients with heart failure with ...